Kobayashi Pharmaceutical Co., Ltd. (KBYPF)
USD 37.43
(6.82%)
USD 37.43
(6.82%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 96.37 Billion JPY | 4.38% |
| 2022 | 92.33 Billion JPY | 4.01% |
| 2021 | 88.77 Billion JPY | 4.11% |
| 2020 | 85.26 Billion JPY | -17.5% |
| 2019 | 103.34 Billion JPY | 0.22% |
| 2018 | 103.12 Billion JPY | 7.95% |
| 2017 | 95.52 Billion JPY | 6.31% |
| 2016 | 89.85 Billion JPY | 12.75% |
| 2015 | 79.69 Billion JPY | 8.24% |
| 2014 | 73.62 Billion JPY | 0.72% |
| 2013 | 73.1 Billion JPY | 4.73% |
| 2012 | 69.8 Billion JPY | -8.8% |
| 2011 | 76.53 Billion JPY | 2.53% |
| 2010 | 74.63 Billion JPY | 3.83% |
| 2009 | 71.88 Billion JPY | 4.67% |
| 2008 | 68.68 Billion JPY | -15.41% |
| 2007 | 81.18 Billion JPY | -4.17% |
| 2006 | 84.71 Billion JPY | 6.41% |
| 2005 | 79.61 Billion JPY | 10.89% |
| 2004 | 71.79 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 20.95 Billion JPY | -25.89% |
| 2024 Q2 | 19.8 Billion JPY | -5.47% |
| 2023 Q2 | 23.16 Billion JPY | 19.84% |
| 2023 FY | 96.37 Billion JPY | 4.38% |
| 2023 Q3 | 25.61 Billion JPY | 10.58% |
| 2023 Q4 | 28.27 Billion JPY | 10.38% |
| 2023 Q1 | 19.32 Billion JPY | -28.34% |
| 2022 FY | 92.33 Billion JPY | 4.01% |
| 2022 Q2 | 22.29 Billion JPY | 19.58% |
| 2022 Q1 | 18.64 Billion JPY | -26.51% |
| 2022 Q4 | 26.97 Billion JPY | 10.42% |
| 2022 Q3 | 24.42 Billion JPY | 9.59% |
| 2021 FY | 88.77 Billion JPY | 4.11% |
| 2021 Q4 | 25.36 Billion JPY | 6.63% |
| 2021 Q1 | 17.79 Billion JPY | -25.89% |
| 2021 Q2 | 21.83 Billion JPY | 22.7% |
| 2021 Q3 | 23.78 Billion JPY | 8.96% |
| 2020 FY | 85.26 Billion JPY | -17.5% |
| 2020 Q4 | 24 Billion JPY | 5.15% |
| 2020 Q3 | 22.83 Billion JPY | 12.99% |
| 2020 Q2 | 20.2 Billion JPY | 10.89% |
| 2020 Q1 | 18.22 Billion JPY | -36.32% |
| 2019 FY | 103.34 Billion JPY | 0.22% |
| 2019 Q4 | 28.61 Billion JPY | 3.14% |
| 2019 Q3 | 27.74 Billion JPY | 7.93% |
| 2019 Q2 | 25.7 Billion JPY | 20.75% |
| 2019 Q1 | 21.28 Billion JPY | -28.89% |
| 2018 Q1 | 21.27 Billion JPY | -23.94% |
| 2018 Q2 | 25.06 Billion JPY | 17.8% |
| 2018 FY | 103.12 Billion JPY | 7.95% |
| 2018 Q4 | 29.93 Billion JPY | 11.52% |
| 2018 Q3 | 26.84 Billion JPY | 7.1% |
| 2017 Q4 | 27.97 Billion JPY | 11.99% |
| 2017 FY | 95.52 Billion JPY | 6.31% |
| 2017 Q1 | 19.3 Billion JPY | 0.0% |
| 2017 Q2 | 23.26 Billion JPY | 20.54% |
| 2017 Q3 | 24.97 Billion JPY | 7.35% |
| 2016 FY | 89.85 Billion JPY | 12.75% |
| 2016 Q2 | 22.8 Billion JPY | 23.71% |
| 2016 Q3 | 22.65 Billion JPY | -0.68% |
| 2016 Q1 | 18.43 Billion JPY | -21.04% |
| 2015 FY | 79.69 Billion JPY | 8.24% |
| 2015 Q1 | 17.01 Billion JPY | -20.99% |
| 2015 Q4 | 23.35 Billion JPY | 17.32% |
| 2015 Q2 | 18 Billion JPY | 5.81% |
| 2015 Q3 | 19.9 Billion JPY | 10.56% |
| 2014 Q4 | 21.53 Billion JPY | 16.63% |
| 2014 Q2 | 16.61 Billion JPY | -3.54% |
| 2014 FY | 73.62 Billion JPY | 0.72% |
| 2014 Q3 | 18.46 Billion JPY | 11.14% |
| 2014 Q1 | 17.22 Billion JPY | -18.32% |
| 2013 Q3 | 18.32 Billion JPY | 11.27% |
| 2013 Q4 | 21.08 Billion JPY | 15.06% |
| 2013 Q2 | 16.46 Billion JPY | 12.11% |
| 2013 Q1 | 14.69 Billion JPY | -28.03% |
| 2013 FY | 73.1 Billion JPY | 4.73% |
| 2012 Q1 | 16.6 Billion JPY | -24.38% |
| 2012 Q2 | 16.92 Billion JPY | 1.88% |
| 2012 Q4 | 20.41 Billion JPY | 14.8% |
| 2012 Q3 | 17.77 Billion JPY | 5.07% |
| 2012 FY | 69.8 Billion JPY | -8.8% |
| 2011 Q2 | 18.03 Billion JPY | 13.37% |
| 2011 Q4 | 21.96 Billion JPY | 10.26% |
| 2011 Q3 | 19.92 Billion JPY | 10.45% |
| 2011 FY | 76.53 Billion JPY | 2.53% |
| 2011 Q1 | 15.9 Billion JPY | -25.59% |
| 2010 Q1 | 14.08 Billion JPY | -34.25% |
| 2010 Q2 | 17.95 Billion JPY | 27.49% |
| 2010 Q3 | 19.39 Billion JPY | 8.05% |
| 2010 FY | 74.63 Billion JPY | 3.83% |
| 2010 Q4 | 21.38 Billion JPY | 10.23% |
| 2009 Q1 | 14.54 Billion JPY | -27.78% |
| 2009 Q3 | 18.73 Billion JPY | 6.09% |
| 2009 Q4 | 21.41 Billion JPY | 14.32% |
| 2009 FY | 71.88 Billion JPY | 4.67% |
| 2009 Q2 | 17.65 Billion JPY | 21.4% |
| 2008 Q4 | 20.13 Billion JPY | 12.99% |
| 2008 FY | 68.68 Billion JPY | -15.41% |
| 2008 Q3 | 17.82 Billion JPY | 0.0% |
| 2007 FY | 81.18 Billion JPY | -4.17% |
| 2006 FY | 84.71 Billion JPY | 6.41% |
| 2005 FY | 79.61 Billion JPY | 10.89% |
| 2004 FY | 71.79 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | 64.43 Thousand USD | -149582392.628% |
| Bruush Oral Care Inc. | 292.91 Thousand USD | -32901940.844% |
| CCA Industries, Inc. | 6.4 Million USD | -1503647.667% |
| DSwiss, Inc. | 359.22 Thousand USD | -26828767.701% |
| EOS, Inc. | 193.87 Thousand USD | -49709767.596% |
| Greyson International, Inc. | -55.53 Thousand USD | 173528923.941% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | 119.99 Thousand USD | -80313902.617% |
| Infusion Brands International, Inc. | 7.33 Million USD | -1313679.857% |
| Mandom Corporation | 197.69 Million USD | -48649.927% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | - USD | -Infinity% |
| Oliveda International, Inc. | 1.57 Million USD | -6131562.527% |
| PacificHealth Laboratories, Inc. | 2.98 Million USD | -3225850.06% |
| Prosperous Future Holdings Limited | 15.12 Million USD | -637017.839% |
| PURE Bioscience, Inc. | 1.15 Million USD | -8365872.222% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | 20 Thousand USD | -481879900.0% |
| Sentient Brands Holdings Inc. | 100.00 USD | -96375999900.0% |
| Sunset Capital Assets, Inc. | -47.11 Thousand USD | 204537547.739% |
| The Stephan Co. | 2.62 Million USD | -3667175.495% |
| Turner Valley Oil & Gas, Inc. | -835.00 USD | 11542036028.144% |
| Winning Brands Corporation | 59.21 Thousand USD | -162769702.398% |
| Warpaint London PLC | 43.15 Million USD | -223223.79% |
| Zoono Group Limited | -625.36 Thousand USD | 15411235.239% |
| Zurvita Holdings, Inc. | 1.37 Million USD | -6984604.471% |